Brady Todd C

CIK 00015791795 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001579179

Recent Transactions

50 trades

Award
Aldeyra Therapeutics, Inc.$ALDX
Bonus Units
2026-03-27+632,318→ 632,318 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (right to buy)
2026-03-27+1,880,510→ 1,880,510 total
Disposition to Issuer
Evoke Pharma Inc$EVOK
Stock Option (Right to Buy)
2025-12-17−1,218→ 0 total
Disposition to Issuer
Evoke Pharma Inc$EVOK
Stock Option (Right to Buy)
2025-12-17−5,833→ 0 total
Disposition to Issuer
Evoke Pharma Inc$EVOK
Stock Option (Right to Buy)
2025-12-17−1,187→ 0 total
Disposition from Tender
Evoke Pharma Inc$EVOK
Common Stock
2025-12-16−27→ 0 total
Award
Evoke Pharma Inc$EVOK
Stock Option (Right to Buy)
2025-05-21+1,187→ 8,238 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (right to buy)
2025-03-04+809,710→ 809,710 total
Award
Evoke Pharma Inc$EVOK
Stock Option (Right to Buy)
2025-01-28+5,833→ 5,833 total
Award
Evoke Pharma Inc$EVOK
Stock Option (Right to Buy)
2024-05-22+14,625→ 14,625 total
Sale
Aldeyra Therapeutics, Inc.$ALDX
Common Stock
2024-03-12$3.05/sh−85,324→ 1,471,298 total
Sale
Aldeyra Therapeutics, Inc.$ALDX
Common Stock
2024-03-11$3.27/sh−97,914→ 1,556,622 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (right to buy)
2024-03-09+1,081,201→ 1,081,201 total
Exercise/Conversion
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (right to buy)
2023-09-07−32,953→ 0 total
Exercise/Conversion
Aldeyra Therapeutics, Inc.$ALDX
Common Stock
2023-09-07$0.55/sh+48,021→ 1,728,343 total
Exercise/Conversion
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (right to buy)
2023-09-07−192,084→ 0 total
Exercise/Conversion
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (right to buy)
2023-09-07−48,021→ 0 total
Exercise/Conversion
Aldeyra Therapeutics, Inc.$ALDX
Common Stock
2023-09-07$0.55/sh+32,953→ 1,680,322 total
Tax Payment
Aldeyra Therapeutics, Inc.$ALDX
Common Stock
2023-09-07$7.22/sh−73,807→ 1,654,536 total
Exercise/Conversion
Aldeyra Therapeutics, Inc.$ALDX
Common Stock
2023-09-07$0.55/sh+192,084→ 1,647,369 total
Award
Evoke Pharma Inc$EVOK
Stock Option (Right to Buy)
2023-05-10+14,625→ 14,625 total
Disposition to Issuer
F-star Therapeutics, Inc.
Stock Option (right to buy)
2023-03-08−20,000→ 0 total
Disposition from Tender
F-star Therapeutics, Inc.
Common Stock
2023-03-08$7.12/sh−15,004→ 0 total
Disposition to Issuer
F-star Therapeutics, Inc.
Stock Option (right to buy)
2023-03-08−20,000→ 0 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (right to buy)
2023-02-28+250,000→ 250,000 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Common Stock
2023-02-28+238,750→ 1,455,285 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Bonus Units
2022-07-15+604,308→ 604,308 total
Purchase
Aldeyra Therapeutics, Inc.$ALDX
Common Stock
2022-06-23$3.36/sh+17,700→ 1,216,535 total
Award
F-star Therapeutics, Inc.
Stock Option
2022-06-17+20,000→ 20,000 total
Award
Evoke Pharma Inc$EVOK
Stock Option (Right to Buy)
2022-04-27+57,750→ 57,750 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Common Stock
2022-03-30+250,000→ 1,198,835 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Employee Stock Option (Right to Buy)
2022-03-30+250,000→ 250,000 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Bonus Units
2022-03-30+207,758→ 207,758 total
Award
F-star Therapeutics, Inc.
Stock Option
2021-06-04+20,000→ 20,000 total
Award
Evoke Pharma Inc$EVOK
Stock Option (Right to Buy)
2021-05-05+57,750→ 57,750 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Employee Stock Option (Right to Buy)
2021-04-12+250,000→ 250,000 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Common Stock
2021-04-12+46,619→ 948,835 total
Other
F-star Therapeutics, Inc.
Stock Option (right to buy)
2020-11-20−7,500→ 0 total
Other
F-star Therapeutics, Inc.
Stock Option (right to buy)
2020-11-20−5,500→ 0 total
Other
F-star Therapeutics, Inc.
Stock Option (right to buy)
2020-11-20−7,500→ 0 total
Other
F-star Therapeutics, Inc.
Stock Option (right to buy)
2020-11-20−5,500→ 0 total
Other
F-star Therapeutics, Inc.
Warrant (right to buy)
2020-11-20−10,964→ 0 total
Other
F-star Therapeutics, Inc.
Stock Option (right to buy)
2020-11-20−11,000→ 0 total
Other
F-star Therapeutics, Inc.
Warrants
2020-11-19−2,741→ 0 total
Award
F-star Therapeutics, Inc.
Common Stock
2020-09-30+9,235→ 60,016 total
Award
F-star Therapeutics, Inc.
Common Stock
2020-06-30+8,418→ 50,781 total
Award
F-star Therapeutics, Inc.
Stock Option (right to buy)
2020-06-24+7,500→ 7,500 total
Award
Evoke Pharma Inc$EVOK
Stock Option (Right to Buy)
2020-05-27+57,750→ 57,750 total
Award
F-star Therapeutics, Inc.
Common Stock
2020-03-31+13,306→ 42,363 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Bonus Units
2020-03-02+450,865→ 450,865 total

Companies

Recent Filings

Address

C/O ALDEYRA THERAPEUTICS, INC. 131 HARTWELL AVENUE

LEXINGTON, MA, 02421

View on SEC.gov